EP Patent

EP0674513A1 — Retroviral protease inhibiting compounds.

Assigned to Abbott Laboratories · Expires 1995-10-04 · 31y expired

What this patent protects

A retroviral protease inhibiting compound of formula (A) is disclosed.

USPTO Abstract

A retroviral protease inhibiting compound of formula (A) is disclosed.

Drugs covered by this patent

Patent Metadata

Patent number
EP0674513A1
Jurisdiction
EP
Classification
—
Expires
1995-10-04
Drug substance claim
No
Drug product claim
No
Assignee
Abbott Laboratories
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.